Scholar Rock Removes Catalent Indiana From Apitegromab BLA as Fill-Finish Facility

BLA FilingApitegromabNegative

AI Analysis

Summary

Scholar Rock has removed Catalent's Indiana facility from the Apitegromab BLA as the fill-finish manufacturing facility, representing a change to the regulatory submission.

Outcome Details

Catalent Indiana facility removed from BLA as fill-finish facility

Importance:5/10

Sentiment:

-0.30

BLAmanufacturingregulatoryfacility_change

Related Companies

$CTLT

Read the original article

Published by yahoo_finance on August 21, 2026 1:35 PM

Read Original